Back to Feed
ClinicalTrials.gov|Clinical Trial
Stem Cells for Erectile Dysfunction Post RALP
The Methodist Hospital Research Institute
Abstract
This is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and combination effects of active treatment versus placebo in promoting the recovery of erectile function in patients undergoing radical retropubic prostatectomy (RALP) of localized prostate cancer. Phase: PHASE1, PHASE2 Status: NOT_YET_RECRUITING Conditions: Erectile Dysfunction; Prostate Cancer Interventions: Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office; Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR; Placebo in the OR; Placebo in clinic
Keywords
Erectile DysfunctionProstate Cancer